GEN Exclusives

More »

GEN News Highlights

More »
Jan 16, 2007

Cytonet and Vesta Therapeutics Collaborate on Liver Cell Therapy

  • Cytonet and Vesta Therapeutics signed a mutual strategic collaboration agreement that involves the construction of a GMP facility, in accordance with European standards, on the premises of Vesta Therapeutics in Durham, NC. Liver cell products for Cytonet’s clinical trials will be produced at the facility in the future.

    Cytonet says it has managed to refine techniques of cell isolation and processing to the extent that human liver cells can be obtained in medicinal product quality in a routine production process. The goal is to treat various liver disease.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?